What we know is people on GLP-1 receptor agonists eat on average up to 40% fewer overall calories (Christensen et al, 2024)
This produces muscle loss, metabolic slowdown, and nutrient deficiencies
This technology works, but it demands strict conditions: the tablet must be taken on an empty stomach with no more than four ounces of water, followed by a 30-minute fast before eating, drinking, or taking other oral medications
Large-scale clinical trials tracking once-weekly therapies show that symptoms are typically mild-to-moderate, temporary, and highly dose-dependent
Long-term use may cause skin thinning, irritation, or absorption into the body
Rotating injection sites and using proper technique significantly reduces bruising frequency